Location History:
- Sodegaura, JP (2011 - 2013)
- Chiba, JP (2012 - 2013)
Company Filing History:
6 out of 142 
1 out of 189 Years Active: 2011-2013
Title: Shigeyuki Tanifuji: Innovator in Amyloid Research
Introduction
Shigeyuki Tanifuji is a prominent inventor based in Sodegaura, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of compounds that target amyloid proteins. With a total of 6 patents to his name, Tanifuji's work is paving the way for advancements in diagnostic imaging and therapeutic applications.
Latest Patents
Tanifuji's latest patents focus on compounds that exhibit affinity for amyloid. One of his notable inventions provides a compound that not only has a strong affinity for amyloid but also demonstrates rapid clearance from normal tissues while minimizing toxicity, including mutagenicity. This compound is represented by a specific formula, where various components are defined to ensure its effectiveness. Another patent describes a compound that serves as a probe for imaging diagnosis, aimed at detecting amyloid deposits in biological tissues. These innovations are crucial for improving diagnostic methods and understanding amyloid-related diseases.
Career Highlights
Throughout his career, Shigeyuki Tanifuji has worked with reputable organizations, including Nihon Medi-Physics Company, Limited and GE Healthcare Limited. His experience in these companies has allowed him to collaborate on various projects that enhance medical imaging and diagnostics.
Collaborations
Tanifuji has collaborated with notable colleagues such as Daisaku Nakamura and Shinya Takasaki. These partnerships have contributed to the advancement of research in the field of amyloid and its implications in health.
Conclusion
Shigeyuki Tanifuji's innovative work in the development of amyloid-targeting compounds highlights his significant role in biomedical research. His contributions are essential for the future of diagnostic imaging and therapeutic strategies.